Targeting chemokines: Pathogens can, why can't we?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cytokine

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cyto.2015.02.011PMID 25753743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis.

  2018cited by this paper
• Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges

  2015cited by this paper
• Sulfated glycans in inflammation.

  2015cited by this paper
• "Chemokine receptors as therapeutic targets: Why aren't there more drugs?".

  2015cited by this paper
• Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine

  2015cited by this paper
• CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis.

  2014cited by this paper
• TSG-6 Inhibits Neutrophil Migration via Direct Interaction with the Chemokine CXCL8

  2014cited by this paper
• Structural Insights into the Interaction between a Potent Anti-inflammatory Protein, Viral CC Chemokine Inhibitor (vCCI), and the Human CC Chemokine, Eotaxin-1*

  2014cited by this paper
• Leukocyte migration into inflamed tissues.

  2014cited by this paper
• Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display*

  2014cited by this paper
• Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sites

  2014cited by this paper
• Treatment with Evasin‐3 abrogates neutrophil‐mediated inflammation in mouse acute pancreatitis

  2014cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

  2014cited by this paper
• Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists

  2014cited by this paper
• The Viral KSHV Chemokine vMIP-II Inhibits the Migration of Naive and Activated Human NK Cells by Antagonizing Two Distinct Chemokine Receptors

  2013cited by this paper
• Rodent Herpesvirus Peru Encodes a Secreted Chemokine Decoy Receptor

  2013cited by this paper
• Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models

  2013cited by this paper
• Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice

  2013cited by this paper
• Pharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis

  2013cited by this paper
• A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications

  2013cited by this paper
• Cytomegalovirus CC Chemokine Promotes Immune Cell Migration

  2012cited by this paper
• Marek's Disease Viral Interleukin-8 Promotes Lymphoma Formation through Targeted Recruitment of B Cells and CD4+ CD25+ T Cells

  2012cited by this paper
• Targeting chemokines and chemokine receptors with antibodies.

  2012cited by this paper
• Glycosaminoglycan analogs as a novel anti-inflammatory strategy

  2012cited by this paper
• An Introduction to Proteoglycans and Their Localization

  2012cited by this paper
• Pharmacological modulation of chemokine receptor function

  2012cited by this paper
• Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.

  2012cited by this paper
• Properties of 7ND-CCL2 are modulated upon fusion to Fc.

  2012cited by this paper
• Site-Directed Mutagenesis of the CC Chemokine Binding Protein 35K-Fc Reveals Residues Essential for Activity and Mutations That Increase the Potency of CC Chemokine Blockade

  2011cited by this paper
• Overcoming hurdles in developing successful drugs targeting chemokine receptors

  2011cited by this paper
• Role for the conserved N-terminal cysteines in the anti-chemokine activities by the chemokine-like protein MC148R1 encoded by Molluscum contagiosum virus.

  2011cited by this paper
• Current Good Manufacturing Practice Production of an Oncolytic Recombinant Vesicular Stomatitis Viral Vector for Cancer Treatment

  2011cited by this paper
• Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.

  2011cited by this paper
• Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.

  2010cited by this paper
• Gastrointestinal , Hepatobiliary and Pancreatic Pathology Treatment with a Novel Chemokine-Binding Protein or Eosinophil Lineage-Ablation Protects Mice from Experimental Colitis

  2010cited by this paper
• Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice

  2010cited by this paper
• SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family

  2010cited by this paper
• Pan–CC Chemokine Neutralization Restricts Splenocyte Egress and Reduces Inflammation in a Model of Arthritis

  2010cited by this paper
• The CCL3/Macrophage Inflammatory Protein-1α–Binding Protein Evasin-1 Protects from Graft-versus-Host Disease but Does Not Modify Graft-versus-Leukemia in Mice

  2010cited by this paper
• An Overview on GPCRs and Drug Discovery: Structure-Based Drug Design and Structural Biology on GPCRs

  2009cited by this paper
• Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3

  2009cited by this paper
• Drug discovery targeting the chemokine system--where are we?

  2009cited by this paper
• The Cytomegalovirus UL146 Gene Product vCXCL1 Targets Both CXCR1 and CXCR2 as an Agonist*

  2009cited by this paper
• Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.

  2008cited by this paper
• Structure and Function of A41, a Vaccinia Virus Chemokine Binding Protein

  2008cited by this paper
• Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.

  2008cited by this paper
• The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor

  2008cited by this paper
• Ticks produce highly selective chemokine binding proteins with antiinflammatory activity

  2008cited by this paper
• Regulation of chemokine activity by posttranslational modification.

  2008cited by this paper
• Molecular Cloning and Characterization of a Highly Selective Chemokine-binding Protein from the Tick Rhipicephalus sanguineus*

  2007cited by this paper
• An Ectromelia Virus Protein That Interacts with Chemokines through Their Glycosaminoglycan Binding Domain

  2007cited by this paper
• Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140)

  2007cited by this paper
• Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor

  2007cited by this paper
• Eukaryotic expression of the broad‐spectrum chemokine receptor antagonist vMIP‐II and its effects on T‐cell function in vitro and in vivo

  2006cited by this paper
• The Chemokine Decoy Receptor M3 Blocks CC Chemokine Ligand 2 and CXC Chemokine Ligand 13 Function In Vivo1

  2006cited by this paper
• Identification and Characterization of U83A Viral Chemokine, a Broad and Potent β-Chemokine Agonist for Human CCRs with Unique Selectivity and Inhibition by Spliced Isoform1

  2006cited by this paper
• A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.

  2006cited by this paper
• A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.

  2006cited by this paper
• Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1β

  2006cited by this paper
• Characterization of the Interaction between Tumor Necrosis Factor-stimulated Gene-6 and Heparin

  2005cited by this paper
• Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity

  2005cited by this paper
• Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1α in Induction of Experimental Autoimmune Myocarditis and Effective Anti–Monocyte Chemoattractant Protein-1 Gene Therapy

  2005cited by this paper
• The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors.

  2004cited by this paper
• The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans

  2004cited by this paper
• A macrophage inflammatory protein homolog encoded by guinea pig cytomegalovirus signals via CC chemokine receptor 1.

  2003cited by this paper
• Kaposi’s sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells

  2003cited by this paper
• Disruption of CCL21-Induced Chemotaxis In Vitro and In Vivo by M3, a Chemokine-Binding Protein Encoded by Murine Gammaherpesvirus 68

  2003cited by this paper
• The Gammaherpesvirus Chemokine Binding Protein Binds to the N Terminus of CXCL8

  2003cited by this paper
• Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Inhibition of Airway Inflammation by Amino-Terminally Modified RANTES/CC Chemokine Ligand 5 Analogues Is Not Mediated through CCR3

  2003cited by this paper
• A chemokine receptor antagonist inhibits experimental breast tumor growth.

  2003cited by this paper
• Structural basis of chemokine sequestration by a herpesvirus decoy receptor.

  2002cited by this paper
• Comprehensive Mapping of Poxvirus vCCI Chemokine-binding Protein

  2002cited by this paper
• Glycosaminoglycan Binding Properties of the Myxoma Virus CC-chemokine Inhibitor, M-T1*

  2001cited by this paper
• Marek's Disease Virus (MDV) Encodes an Interleukin-8 Homolog (vIL-8): Characterization of the vIL-8 Protein and a vIL-8 Deletion Mutant MDV

  2001cited by this paper
• Selective recruitment of Th2‐type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein‐II

  2001cited by this paper
• The Chemokine RANTES Is a Crucial Mediator of the Progression from Acute to Chronic Colitis in the Rat1

  2001cited by this paper
• The herpesvirus 8‐encoded chemokine vMIP‐II, but not the poxvirus‐encoded chemokine MC148, inhibits the CCR10 receptor

  2001cited by this paper
• The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC

  2001cited by this paper
• Identification of a Gammaherpesvirus Selective Chemokine Binding Protein That Inhibits Chemokine Action

  2000cited by this paper
• Tat Protein Is an HIV-1-Encoded β-Chemokine Homolog That Promotes Migration and Up-Regulates CCR3 Expression on Human FcεRI+ Cells1

  2000cited by this paper
• The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury.

  2000cited by this paper
• KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells.

  2000cited by this paper
• Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1.

  2000cited by this paper
• Differential Activation of CC Chemokine Receptors by AOP-RANTES*

  2000cited by this paper
• A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum

  2000cited by this paper
• Local Blockade of Allergic Airway Hyperreactivity and Inflammation by the Poxvirus-Derived Pan-CC-Chemokine Inhibitor vCCI1

  2000cited by this paper
• A Broad Spectrum Secreted Chemokine Binding Protein Encoded by a Herpesvirus

  2000cited by this paper
• HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8

  1999cited by this paper
• CC Chemokine Receptor-3 Undergoes Prolonged Ligand-induced Internalization*

  1999cited by this paper
• The Kaposi's Sarcoma–related Herpesvirus (KSHV)-encoded Chemokine vMIP-I is a Specific Agonist for the CC Chemokine Receptor (CCR)8

  1999cited by this paper
• Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host.

  1999cited by this paper
• Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment

  1999cited by this paper
• In Vivo Inhibition of CC and CX3C Chemokine–induced Leukocyte Infiltration and Attenuation of Glomerulonephritis in Wistar-Kyoto (WKY) Rats by vMIP-II

  1998cited by this paper
• Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity

  1998cited by this paper
• Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus.

  1998cited by this paper
• Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog.

  1998cited by this paper
• Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

  1997cited by this paper
• Functional characterization of the C---C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2.

  1997cited by this paper

• Inhibiting cancer metastasis with water-solubilized membrane receptor CXCR4QTY-Fc as a molecular trap.

  2025cites this paper
• Ticks’ tricks: immunomodulatory effects of ixodid tick saliva at the cutaneous tick-host interface

  2025cites this paper
• C–C Motif chemokine receptor-2 blockade ameliorates pulmonary hypertension in rats and synergizes with a pulmonary vasodilator

  2024cites this paper
• Mesenchymal stem cells enhance CCL8 expression by podocytes in lupus-prone MRL.Faslpr mice

  2023cites this paper
• Analysis of Chemokine-to-GAG Interactions in Model of Donor Renal Allograft Transplant.

  2023cites this paper
• Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2

  2023cites this paper
• Pathogen recognition by sensory neurons: hypotheses on the specificity of sensory neuron signaling

  2023cites this paper
• Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors.

  2023cites this paper
• Chemokines form complex signals during inflammation and disease that can be decoded by extracellular matrix proteoglycans

  2022cites this paper
• The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology

  2022cites this paper
• Immunomodulatory Proteins in Tick Saliva From a Structural Perspective

  2021cites this paper
• The binding and specificity of chemokine binding proteins, through the lens of experiment and computation

  2021cites this paper
• Analysis of combinatorial chemokine receptor expression dynamics using multi-receptor reporter mice

  2021cites this paper
• Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody

  2020cites this paper
• Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates

  2020cites this paper
• Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine‐mediated leukocyte recruitment

  2020cites this paper
• The chemokine CCL7 regulates invadopodia maturation and MMP-9 mediated collagen degradation in liver-metastatic carcinoma cells.

  2020cites this paper
• Tick Saliva Protein Evasin-3 Allows for Visualization of Inflammation in Arteries through Interactions with CXC-Type Chemokines Deposited on Activated Endothelium

  2020cites this paper
• Using evasins to target the chemokine network in inflammation.

  2020cites this paper
• Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting

  2020cites this paper
• Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2

  2019cites this paper
• A knottin scaffold directs the CXC-chemokine–binding specificity of tick evasins

  2019cites this paper
• Chemokines and Chemokine Receptors

  2019cites this paper
• More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis

  2019cites this paper
• Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis

  2018cites this paper
• The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins

  2018cites this paper
• A drug development perspective on targeting tumor‐associated myeloid cells

  2018cites this paper
• Novel Anti-Inflammatory Peptides Based on Chemokine–Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis

  2018cites this paper
• Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4

  2018cites this paper
• Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines

  2018cites this paper
• Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1+ and CCR5+ Cells in Chronic Chagasic Cardiomyopathy

  2018influential citation
• Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis

  2018cites this paper
• Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets

  2018cites this paper
• The chemokine fragment CXCL9(74–103) diminishes neutrophil recruitment and joint inflammation in antigen‐induced arthritis

  2018cites this paper
• Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise

  2018cites this paper
• Selective Deletion of Heparan Sulfotransferase Enzyme, Ndst1, in Donor Endothelial and Myeloid Precursor Cells Significantly Decreases Acute Allograft Rejection

  2018cites this paper
• The chemokine receptor CXCR2 contributes to murine adipocyte development

  2018cites this paper
• Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer’s patients in a human blood brain barrier model

  2018cites this paper
• Physiology and Pathology of Innate Immune Response Against Pathogens

  2017cites this paper
• Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation

  2017cites this paper
• Microfluidics to define leukocyte migration patterns

  2017cites this paper
• Corrigendum: CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses

  2017cites this paper
• Mechanisms of Regulation of the Chemokine-Receptor Network

  2017cites this paper
• Enabling T Cell Recruitment to Tumours as a Strategy for Improving Adoptive T Cell Therapy

  2017cites this paper
• Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities

  2017cites this paper
• Evasin‐displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco‐2 cells

  2017cites this paper
• Chemokines from a Structural Perspective

  2017cites this paper
• Author Correction: Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities

  2017cites this paper
• CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses

  2017cites this paper
• Altered expression of glial markers, chemokines, and opioid receptors in the spinal cord of type 2 diabetic monkeys.

  2017cites this paper
• Circulating chemokine ligand levels before and after successful kidney transplantation

  2016cites this paper
• Chemokine genetic polymorphism in human health and disease.

  2016cites this paper
• Parallel Evolution of Chemokine Binding by Structurally Related Herpesvirus Decoy Receptors.

  2016cites this paper
• Syddansk Universitet Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 ( CCR 5 )

  2016cites this paper
• The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions*

  2016cites this paper
• Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5)*

  2016cites this paper
• Chemokines and Chemokine Receptors in the Development of Lupus Nephritis

  2016cites this paper
• High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors

  2016cites this paper
• Preparation and Characterization of Glycosaminoglycan Chemokine Coreceptors.

  2016cites this paper
• IMMUNOLOGICAL MECHANISMS UNDERLYING INFLAMMATORY BOWEL DISEASE

  2015cites this paper
• Genetic Susceptibility to Cardiac and Digestive Clinical Forms of Chronic Chagas Disease: Involvement of the CCR5 59029 A/G Polymorphism

  2015cites this paper
• Analysis of combinatorial chemokine receptor expression dynamics using multi-receptor reporter 1 mice . 2 3

  year unknowncites this paper